Navam Welihinda is CFO at HashiCorp, Inc. (HCP). They have made 25 open-market trades across 2 companies since 2021, most recently 2026-09-09.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 25 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ESTC | 200,293 | $17.0M |
| HCP | 105,883 | $3.7M |
| Total | $20.7M |
Shares reported on the most recent Form 4, priced at the 2026-09-10 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ESTC | SELL | 2026-09-09 | 2026-09-10 | $87.78 | $787K | — | — | — |
| ESTC | SELL | 2026-06-09 | 2026-06-10 | $60.61 | $786K | -0.7% | +1.4% | +48.9% |
| ESTC | SELL | 2026-03-09 | 2026-03-10 | $52.28 | $169K | +1.6% | -14.3% | +18.4% |
| ESTC | SELL · 10b5-1 | 2025-12-10 | 2025-12-11 | $74.51 | $156K | -2.7% | -3.0% | -33.2% |
| ESTC | SELL | 2025-12-09 | 2025-12-10 | $75.05 | $649K | +0.6% | +0.8% | -33.5% |
| ESTC | SELL · 10b5-1 | 2025-10-06 | 2025-10-07 | $84.58 | $212K | -0.4% | +6.2% | -8.8% |
| ESTC | SELL | 2025-09-09 | 2025-09-10 | $90.12 | $629K | -1.5% | -4.3% | -17.4% |
| ESTC | SELL | 2025-06-09 | 2025-06-10 | $86.91 | $393K | -2.9% | +0.2% | +9.2% |
| HCP | SELL | 2024-09-20 | 2024-09-23 | $33.84 | $1.2M | +0.4% | -0.1% | +1.5% |
| HCP | SELL · 10b5-1 | 2024-08-22 | 2024-08-23 | $33.87 | $169K | -0.4% | -0.1% | -0.0% |
| HCP | SELL · 10b5-1 | 2024-07-22 | 2024-07-24 | $33.50 | $168K | -0.1% | +1.0% | +0.7% |
| HCP | SELL · 10b5-1 | 2024-06-24 | 2024-06-26 | $33.47 | $1.2M | -0.1% | +0.5% | +1.2% |
| HCP | SELL | 2024-06-20 | 2024-06-24 | $33.26 | $1.2M | +0.7% | +0.3% | +1.1% |
| HCP | SELL · 10b5-1 | 2024-05-22 | 2024-05-23 | $33.34 | $333K | +1.4% | +0.5% | +1.9% |
| HCP | SELL · 10b5-1 | 2024-04-22 | 2024-04-24 | $26.38 | $132K | -0.6% | +1.2% | +1.8% |
| HCP | SELL · 10b5-1 | 2024-03-22 | 2024-03-26 | $27.09 | $1.1M | -2.6% | +21.6% | +24.0% |
| HCP | SELL | 2024-03-21 | 2024-03-22 | $27.39 | $501K | -5.0% | -9.1% | +23.3% |
| HCP | SELL | 2024-02-26 | 2024-02-28 | $25.00 | $63K | -2.2% | -3.3% | +25.4% |
| HCP | SELL · 10b5-1 | 2024-02-22 | 2024-02-26 | $21.84 | $55K | +3.4% | +6.1% | +31.5% |
| HCP | SELL · 10b5-1 | 2024-02-09 | 2024-02-13 | $25.00 | $125K | +5.0% | +7.1% | +37.0% |
| HCP | SELL · 10b5-1 | 2024-01-22 | 2024-01-23 | $21.94 | $107K | +2.7% | -4.4% | +8.6% |
| HCP | SELL · 10b5-1 | 2023-12-22 | 2023-12-27 | $23.48 | $1.7M | -9.2% | -7.3% | +10.6% |
| HCP | SELL | 2023-12-21 | 2023-12-22 | $22.80 | $753K | -6.7% | -7.5% | +15.8% |
| HCP | SELL · 10b5-1 | 2023-12-05 | 2023-12-07 | $25.00 | $125K | +15.1% | +13.2% | +34.1% |
| HCP | SELL · 10b5-1 | 2023-11-22 | 2023-11-27 | $21.16 | $53K | +20.3% | +18.4% | +21.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.